Cipher Pharmaceuticals Inc (PHE) Stock Price & News

All values in USD	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	12,83 m	12,22 m	12,50 m	12,07 m
Cost of goods sold	2,35 m	2,30 m	2,21 m	2,37 m
Cost of revenue	2,35 m	2,30 m	2,21 m	2,37 m
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3,71 m	3,68 m	2,90 m	3,18 m
Operating expense	5,51 m	5,49 m	4,70 m	4,96 m
Total operating expenses	7,86 m	7,79 m	6,91 m	7,33 m
Operating income	4,97 m	4,43 m	5,60 m	4,73 m
Other non operating income	-	-	-	-
EBT including unusual items	4,26 m	4,61 m	4,95 m	3,64 m
EBT excluding unusual items	4,13 m	4,84 m	4,89 m	3,90 m
Income tax expense	-1,24 m	-8,70 m	-1,21 m	-369,00 k
Effective tax rate	-29,19%	-188,55%	-24,53%	-10,13%
Other operating expenses	-	-	-	-
Net income	5,50 m	13,31 m	6,16 m	4,01 m
Net profit margin	42,87%	108,95%	49,28%	33,26%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	15,00 k
Interest expense	-241,00 k	-109,00 k	-51,00 k	-
Net interest expenses	-241,00 k	-109,00 k	-51,00 k	15,00 k
Depreciation and amortization charges	1,80 m	1,81 m	1,81 m	1,78 m
EBITDA	6,77 m	5,95 m	7,32 m	6,44 m
Gain or loss from assets sale	-	-130,00 k	-57,00 k	-

Finance